Amgen

KYPROLIS

Manufacturer:

Amgen

Kyprolis HCPCS:

J9047

HCPCS Code Descriptor:

Injection, carfilzomib, 1 mg

Category:

J Code

Kyprolis NDCs:

76075-0102-01, 76075-0101-01, 76075-0103-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Kyprolis:

KYPROLIS is an Oncology drug manufactured by Amgen and administered via the Intravenous route of administration. The J Code: J9047 is aligned to the drug KYPROLIS.

ACCESS PRICING AND MORE BY REGISTERING

J9047 Added Date:

January 1, 2014

J9047 Effective Date:

January 1, 2014

J9047 Termination Date:

HCPCS Active

Kyprolis billing and coding information can be found through Amgen at the link below:
Kyprolis patient assistance information can be found through Amgen Assist at the URL: https://www.amgenassist.com/copay
KYPROLIS prescribing information can be found at the link below:
Information regarding KYPROLIS’s side effects can be found at MedlinePlus